Development
Predictive Oncology Inc.
POAI
$0.9386
-$0.0114-1.20%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 27.97% | 28.33% | -34.74% | -30.93% | -9.45% |
| Total Depreciation and Amortization | -32.32% | -19.32% | -8.54% | -2.04% | 5.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -63.78% | -71.12% | 62.14% | 58.51% | -9.78% |
| Change in Net Operating Assets | -42.49% | 192.21% | 187.02% | 172.57% | 119.20% |
| Cash from Operations | -3.59% | 1.26% | -6.05% | -1.33% | -19.60% |
| Capital Expenditure | 38.74% | 12.57% | 29.29% | 53.88% | 37.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.40% | 60.52% | 69.19% | 47.85% | 57.99% |
| Cash from Investing | 96.34% | 94.99% | 95.71% | 95.52% | -960.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | -100.00% | -67.09% | -87.90% | -87.87% |
| Repurchase of Common Stock | -490.00% | -140.00% | -140.00% | -140.00% | 65.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 88.40% |
| Cash from Financing | -96.47% | -100.41% | -67.01% | -86.66% | -86.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.70% | 18.92% | -198.48% | -122.28% | -141.68% |